Biostar Pharmaceuticals, Inc. – OTC:BSPM

Biostar Pharmaceuticals stock price today

$0
-0.00
-99.9%
Financial Health
0
1
2
3
4
5
6
7
8
9

Biostar Pharmaceuticals stock price monthly change

+7042.86%
month

Biostar Pharmaceuticals stock price quarterly change

+7042.86%
quarter

Biostar Pharmaceuticals stock price yearly change

+900.00%
year

Biostar Pharmaceuticals key metrics

Market Cap
 94
Enterprise value
 2.06M
P/E
 N/A
EV/Sales
 6.48
EV/EBITDA
 0.42
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 0.44
Revenue
 N/A
EBITDA
 4.42M
Income
 313.34K
Revenue Q/Q
 -100%
Revenue Y/Y
 -91.86%
Profit margin
 294.01%
Oper. margin
 876.46%
Gross margin
 -11.56%
EBIT margin
 876.46%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Biostar Pharmaceuticals stock price history

Biostar Pharmaceuticals stock forecast

Biostar Pharmaceuticals financial statements

Profit Margin

Biostar Pharmaceuticals, Inc. (OTC:BSPM): Profit margin
Dec 2016 317.79K 3.38M 1066.12%
Mar 2017 0 -1.05M
Jun 2017 0 -1.36M
Sep 2017 0 -654.86K
BSPM income statement history

Quarterly Earnings

Biostar Pharmaceuticals, Inc. (OTC:BSPM): Earnings per share (EPS)
2011-03-25 4.62 5.04
BSPM earnings history

Debt to Assets

Biostar Pharmaceuticals, Inc. (OTC:BSPM): Debt to assets
Dec 2016 42502438 5.62M 13.23%
Mar 2017 41492576 5.31M 12.8%
Jun 2017 40777321 5.29M 12.98%
Sep 2017 41427266 5.27M 12.74%
BSPM balance sheet history

Cash Flow

Biostar Pharmaceuticals, Inc. (OTC:BSPM): Cash Flow
Dec 2016 4.00M -6.37M 1.69M
Mar 2017 321.12K 0 0
Jun 2017 4.26M -4.36M 0
Sep 2017 -1.40K -44.38K 0
BSPM cash flow history

Biostar Pharmaceuticals alternative data

Biostar Pharmaceuticals
Employees

Biostar Pharmaceuticals, Inc. (OTC:BSPM): Employee count
Aug 2023 200
Sep 2023 200
Oct 2023 200
Nov 2023 200
Dec 2023 200
Jan 2024 200
Feb 2024 200
Mar 2024 200
Apr 2024 200
May 2024 200
Jun 2024 200
Jul 2024 200

Biostar Pharmaceuticals other data

Biostar Pharmaceuticals
Insider Trading

Biostar Pharmaceuticals, Inc. (OTC:BSPM): Insider trades (number of shares)
Period Buy Sel
May 2011 30000 0
Jun 2011 198912 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 13,800 $1.1 $15,180
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 14,350 $1.19 $17,077
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 35,100 $1.23 $43,173
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 22,050 $1.24 $27,298
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 19,700 $1.21 $23,739
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 12,000 $1.22 $14,664
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 34,600 $1.26 $43,700
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 8,600 $1.25 $10,750
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 10,300 $1.24 $12,772
Purchase
WANG RONGHUA director, 10 perc.. Common Stock 6,900 $1.27 $8,763
BSPM insider trading transactions

Biostar Pharmaceuticals
Executives

Insider Compensation
Mr. Ronghua Wang (1956) Chairman, Chief Executive Officer & Pres $16,260
Mr. Zhenghong Wang (1980) Chief Operating Officer
 $6,140

Frequently Asked Questions (FAQ)

  • What's the price of Biostar Pharmaceuticals stock today?

    One share of Biostar Pharmaceuticals stock can currently be purchased for approximately $0.

  • When is Biostar Pharmaceuticals's next earnings date?

    Unfortunately, Biostar Pharmaceuticals's (BSPM) next earnings date is currently unknown.

  • Does Biostar Pharmaceuticals pay dividends?

    No, Biostar Pharmaceuticals does not pay dividends.

  • How much money does Biostar Pharmaceuticals make?

    Biostar Pharmaceuticals has a market capitalization of 94 and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 91.21% to 2.38M US dollars. Biostar Pharmaceuticals made a loss 5.7M US dollars in net income (profit) last year or $5.04 on an earnings per share basis.

  • What is Biostar Pharmaceuticals's stock symbol?

    Biostar Pharmaceuticals, Inc. is traded on the OTC under the ticker symbol "BSPM".

  • What is Biostar Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of Biostar Pharmaceuticals?

    Shares of Biostar Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Biostar Pharmaceuticals's key executives?

    Biostar Pharmaceuticals's management team includes the following people:

    • Mr. Ronghua Wang Chairman, Chief Executive Officer & Pres(age: 69, pay: $16,260)
    • Mr. Zhenghong Wang Chief Operating Officer(age: 45, pay: $6,140)

  • How many employees does Biostar Pharmaceuticals have?

    As Jul 2024, Biostar Pharmaceuticals employs 200 workers.

  • When Biostar Pharmaceuticals went public?

    Biostar Pharmaceuticals, Inc. is publicly traded company for more then 17 years since IPO on 9 Jul 2008.

  • What is Biostar Pharmaceuticals's official website?

    The official website for Biostar Pharmaceuticals is biostarpharmaceuticals.com.

  • Where are Biostar Pharmaceuticals's headquarters?

    Biostar Pharmaceuticals is headquartered at No. 588 Shiji Xi Avenue, Xianyang, SHAANXI.

  • How can i contact Biostar Pharmaceuticals?

    Biostar Pharmaceuticals's mailing address is No. 588 Shiji Xi Avenue, Xianyang, SHAANXI and company can be reached via phone at +86 29 3368 6638.

Biostar Pharmaceuticals company profile:

Biostar Pharmaceuticals, Inc.

biostarpharmaceuticals.com
Exchange:

OTC

Full time employees:

200

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

+86 29 3368 6638
No. 588 Shiji Xi Avenue
Xianyang, SHAANXI 712000

:
ISIN: US0906783016
CUSIP: 090678301